KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
NASDAQ:ALXN
Delisted

Alexion Pharmaceuticals Stock Price (Quote)

$182.50
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $182.50 $182.50 Friday, 27th May 2022 ALXN stock ended at $182.50. During the day the stock fluctuated 0% from a day low at $182.50 to a day high of $182.50.
90 days $182.50 $182.50
52 weeks $174.72 $187.45

Historical Alexion Pharmaceuticals prices

Date Open High Low Close Volume
Feb 29, 2016 $140.80 $140.80 $140.80 $140.80 1 479 500
Feb 26, 2016 $140.16 $140.16 $140.16 $140.16 1 433 000
Feb 25, 2016 $140.54 $140.54 $140.54 $140.54 1 343 300
Feb 24, 2016 $141.97 $141.97 $141.97 $141.97 1 653 800
Feb 23, 2016 $142.06 $142.06 $142.06 $142.06 1 489 700
Feb 22, 2016 $145.32 $145.32 $145.32 $145.32 1 170 800
Feb 19, 2016 $145.89 $145.89 $145.89 $145.89 1 326 700
Feb 18, 2016 $143.15 $143.15 $143.15 $143.15 1 715 700
Feb 17, 2016 $148.60 $148.60 $148.60 $148.60 2 165 700
Feb 16, 2016 $142.39 $142.39 $142.39 $142.39 1 615 100
Feb 12, 2016 $141.11 $141.11 $141.11 $141.11 1 582 000
Feb 11, 2016 $135.36 $135.36 $135.36 $135.36 1 393 400
Feb 10, 2016 $138.82 $138.82 $138.82 $138.82 1 756 100
Feb 09, 2016 $136.46 $136.46 $136.46 $136.46 2 433 200
Feb 08, 2016 $139.15 $139.15 $139.15 $139.15 2 118 700
Feb 05, 2016 $142.28 $142.28 $142.28 $142.28 2 099 800
Feb 04, 2016 $146.02 $146.02 $146.02 $146.02 2 797 700
Feb 03, 2016 $145.97 $145.97 $145.97 $145.97 5 590 200
Feb 02, 2016 $137.36 $137.36 $137.36 $137.36 2 465 500
Feb 01, 2016 $143.50 $143.50 $143.50 $143.50 2 713 500
Jan 29, 2016 $145.93 $145.93 $145.93 $145.93 3 147 900
Jan 28, 2016 $145.61 $145.61 $145.61 $145.61 2 983 400
Jan 27, 2016 $151.12 $151.12 $151.12 $151.12 2 127 500
Jan 26, 2016 $152.64 $152.64 $152.64 $152.64 1 522 300
Jan 25, 2016 $154.54 $154.54 $154.54 $154.54 1 255 200
Click to get the best stock tips daily for free!

About Alexion Pharmaceuticals

Alexion Pharmaceuticals Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. The company offers Soliris (eculizumab), a monoclonal antibody for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a genetic blood disorder; and atypical hemolytic uremic syndrome (aHUS), a genetic disease. It provides Strensiq (asfotase alfa), a targeted enzyme replacement therapy for patients with hypophosp... ALXN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT